ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36937300

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.

Yoon SJ and 14 others. Front Microbiol, 2023. Cited by 76 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Papers, record 36937300. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937300

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
PubMed
Journal
Front Microbiol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
8.93
iCite
Revised in PubMed
2023-03-21
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yoon SJSang Jun
2Yu JSJeong Seok
3Min BHByeong Hyun
4Gupta HHaripriya
5Won SMSung-Min
6Park HJHee Jin
7Han SHSang Hak
8Kim BYByung-Yong
9Kim KHKyung Hwan
10Kim BKByoung Kook

1 to 10 of 15Source PubMed

See all 15 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122,688,341Adipose tissue microRNAs as regulators of CCL2 production in human obesity.Diabetes2012https://conductscience.org/library/papers/22688341PubMed
217,210,919Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17210919PubMed
324,440,671Interactions between the intestinal microbiome and liver diseases.Gastroenterology2014https://conductscience.org/library/papers/24440671PubMed
412,540,388A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle.Am J Clin Nutr2003https://conductscience.org/library/papers/12540388PubMed
534,831,387High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review.Cells2021https://conductscience.org/library/papers/34831387PubMed
625,575,570Food, immunity, and the microbiome.Gastroenterology2015https://conductscience.org/library/papers/25575570PubMed
721,700,865Human fatty liver disease: old questions and new insights.Science2011https://conductscience.org/library/papers/21700865PubMed
823,180,608Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors.Mol Nutr Food Res2013https://conductscience.org/library/papers/23180608PubMed
919,291,789Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.Hepatology2009https://conductscience.org/library/papers/19291789PubMed
1023,117,851Nonalcoholic fatty liver disease in lean individuals in the United States.Medicine (Baltimore)2012https://conductscience.org/library/papers/23117851PubMed

1 to 10 of 48

See all 48 references

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42,883,471Structural Features of a Dancong Tea Polysaccharide and Its Amelioration of Glucolipid Metabolic Disorders Associated with Gut Microbiota Modulation.Foods2026https://conductscience.org/library/papers/42883471PubMed
42,883,357Corncob-Derived Xylo-Oligosaccharides Attenuate Acrylamide-Induced Gut-Liver Toxicity in Mice, Associated with Modulation of Gut Microbiota and SCFA Metabolism.Biology (Basel)2026https://conductscience.org/library/papers/42883357PubMed
42,683,000Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling.Front Med (Lausanne)2026https://conductscience.org/library/papers/42683000PubMed
42,602,883Oral probiotic delivery-based therapeutic strategies for inflammatory bowel disease.Asian J Pharm Sci2026https://conductscience.org/library/papers/42602883PubMed
42,108,649Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH.Gut Microbes2026https://conductscience.org/library/papers/42108649PubMed
42,064,820Role of miRNA signalling in the pathogenesis of MASLD.Front Pharmacol2026https://conductscience.org/library/papers/42064820PubMed
42,057,131Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systems.J Nanobiotechnology2026https://conductscience.org/library/papers/42057131PubMed
42,047,937Synthesis and application of encapsulated Bifidobacterium Longum for mitigation of liver fibrosis via modulation of oxidative stress and inflammation in BDL rat model.World J Microbiol Biotechnol2026https://conductscience.org/library/papers/42047937PubMed
42,015,346Gut microbiome and metabolic health: mechanisms and precision interventions.Gut Microbes2026https://conductscience.org/library/papers/42015346PubMed
41,994,286Probiotics and prebiotics as alternatives to antibiotics in aquaculture: a systematic and bibliometric review of antimicrobial and antioxidant mechanisms.Front Microbiol2026https://conductscience.org/library/papers/41994286PubMed

1 to 10 of 53

See all 53 cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACACA31PubTator's text mininghttps://conductscience.org/library/genes/31NCBI Gene
AHR196PubTator's text mininghttps://conductscience.org/library/genes/196NCBI Gene
CCL26,347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CNBP7,555PubTator's text mininghttps://conductscience.org/library/genes/7555NCBI Gene
DGAT18,694PubTator's text mininghttps://conductscience.org/library/genes/8694NCBI Gene
DGAT284,649PubTator's text mininghttps://conductscience.org/library/genes/84649NCBI Gene
FASN2,194PubTator's text mininghttps://conductscience.org/library/genes/2194NCBI Gene
GAPDH2,597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GPT2,875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
IL1B3,553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene

1 to 10 of 18

See all 18 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36937300

GET https://conductscience.org/api/papers/v1/36937300/references?page=2

API referenceFor AI assistants